Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancerSCHAIRER, Catherine; BROWN, Linda M; MAI, Phuong L et al.Breast cancer research and treatment. 2011, Vol 129, Num 1, pp 117-124, issn 0167-6806, 8 p.Article

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?GREENE, Mark H; MAI, Phuong L; SCHWARTZ, Peter E et al.American journal of obstetrics and gynecology. 2011, Vol 204, Num 1, pp 19-20, issn 0002-9378, 2 p.Article

Physical activity and colon cancer risk among women in the California teachers studyMAI, Phuong L; SULLIVAN-HALLEY, Jane; WEST, Dee W et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 3, pp 517-525, issn 1055-9965, 9 p.Article

Pathological characteristics of BRCA-associated breast cancers in HispanicsLAGOS-JARAMILLO, Veronica I; PRESS, Michael F; RICKER, Charite N et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 281-289, issn 0167-6806, 9 p.Article

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersCOX, David G; SIMARD, Jacques; SZABO, Csilla et al.Human molecular genetics (Print). 2011, Vol 20, Num 23, pp 4732-4747, issn 0964-6906, 16 p.Article

The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindredMAI, Phuong L; FRIEDLANDER, Michael; HEIDENREICH, Axel et al.Urologic oncology. 2010, Vol 28, Num 5, pp 492-499, issn 1078-1439, 8 p.Article

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian CancerBOLTON, Kelly L; CHENEVIX-TRENCH, Georgia; HEALEY, Sue et al.JAMA, the journal of the American Medical Association. 2012, Vol 307, Num 4, pp 382-390, issn 0098-7484, 9 p.Article

Common alleles at 6q25.1 and 1 p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersANTONIOU, Antonis C; KARTSONAKI, Christiana; ZAFFARONI, Daniela et al.Human molecular genetics (Print). 2011, Vol 20, Num 16, pp 3304-3321, issn 0964-6906, 18 p.Article

Confirmation of Family Cancer History Reported in a Population-Based SurveyMAI, Phuong L; GARCEAU, Anne O; GRAUBARD, Barry I et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 10, pp 788-797, issn 0027-8874, 10 p.Article

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive familiesKORDE, Larissa A; MUELLER, Christine M; LOUD, Jennifer T et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 169-173, issn 0167-6806, 5 p.Article

Awareness of Cancer Susceptibility Genetic Testing: The 2000, 2005, and 2010 National Health Interview SurveysMAI, Phuong L; VADAPARAMPIL, Susan Thomas; BREEN, Nancy et al.American journal of preventive medicine (Print). 2014, Vol 46, Num 5, pp 440-448, issn 0749-3797, 9 p.Article

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation CarriersRAMUS, Susan J; KARTSONAKI, Christiana; XIANSHU WANG et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 2, pp 105-116, issn 0027-8874, 12 p.Article

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersENGEL, Christoph; VERSMOLD, Beatrix; GARETH EVANS, D et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 11, pp 2859-2868, issn 1055-9965, 10 p.Article

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk PredictionANTONIOU, Antonis C; BEESLEY, Jonathan; ISAACS, Claudine et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9742-9754, issn 0008-5472, 13 p.Article

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersIM, Kate M; KIRCHHOFF, Tomas; GUIDUCCI, Candace et al.Human genetics. 2011, Vol 130, Num 5, pp 685-699, issn 0340-6717, 15 p.Article

Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumourKRATZ, Christian P; HAN, Summer S; ROSENBERG, Philip S et al.Journal of medical genetics. 2011, Vol 48, Num 7, pp 473-476, issn 0022-2593, 4 p.Article

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancerGIERACH, Gretchen L; LOUD, Jennifer T; CALZONE, Kathleen A et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 245-255, issn 0167-6806, 11 p.Article

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersANTONIOU, Antonis C; SINILNIKOVA, Olga M; NEUHAUSEN, Susan L et al.Human molecular genetics (Print). 2009, Vol 18, Num 22, pp 4442-4456, issn 0964-6906, 15 p.Article

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer : Design and Baseline Characteristics: A Gynecologic Oncology Group StudyGREENE, Mark H; PIEDMONTE, Marion; BOGGESS, John et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 3, pp 594-604, issn 1055-9965, 11 p.Article